Express News | Repligen Corp : RBC Cuts Target Price to $189 From $202
JP Morgan Maintains Overweight on Repligen, Lowers Price Target to $190
Repligen Analyst Ratings
Repligen | 10-Q: Quarterly report
Wolfe Research Upgrades Repligen to Outperform From Peerperform
Repligen Targets 10% to 15% Growth in Proteins for 2025 Following New Resin Launches
William Blair Maintains Repligen(RGEN.US) With Buy Rating
Repligen's Strong Q1 Performance and Strategic Acquisition Justify Buy Rating
Repligen Corporation Reports Strong Q1 2025 Financial Results With 10% Revenue Growth and 72% Increase in Adjusted Operating Income
Repligen Corp Q1 Profit Increases, Beats Estimates
Express News | Repligen Corp: Working to Navigate Through Current Economic Environment and See Minimal Impact From Tariffs on EPS
Express News | Repligen Corp FY2025 Shr View $1.71, Rev View $700.4 Mln -- LSEG IBES Data
Express News | Repligen Corp: Reiterates 2025 Full Year Organic Revenue Guidance of 9.5% - 13.5%
Repligen | 8-K: Repligen Reports First Quarter 2025 Financial Results
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 Revenue $169.2M, Vs. FactSet Est of $163.7M
Express News | Repligen Outlook FY Revenue USD 695-720 Million
GUIDANCE: (RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2025 Adjusted EPS Range $1.63 - $1.72
Express News | Repligen Q1 Revenue USD 169 Million Vs. IBES Estimate USD 163.8 Million
Express News | Repligen Q1 Adjusted Operating Income USD 23 Million Vs. IBES Estimate USD 18 Million
Press Release: Repligen Reports First Quarter 2025 Financial Results